The innate host defense against influenza virus is largely dependent on the type I interferon (IFN) system. However, surprisingly little is known about the cellular source of IFN in the infected lung. To clarify this question, we employed a reporter mouse that contains the firefly luciferase gene in place of the IFN-β coding region. IFN-β-producing cells were identified either by simultaneous immunostaining of lungs for luciferase and cellular markers or by generating conditional reporter mice that express luciferase exclusively in defined cell types.
Introduction
Type I interferons (IFN) represent essential components of the antiviral host defense which link innate and adaptive immunity . The family of type I IFN in mammals typically includes more than 10 different IFN-α subtypes, a single IFN-β and minor subtypes such as IFN-ω or IFN-ε. These various IFN genes are usually induced simultaneously in response to virus infection, although the expression profiles of different IFN genes might differ considerably depending on the producer cell type and nature of stimulus (7, 16, 34) . IFN-β is considered to be a master regulator of type I IFN synthesis, as it appears early after viral infection and thereby primes expression of IFN genes . For signaling, all type I IFN family members bind to the same heterodimeric IFN-α/β receptor complex which is present on most if not all nucleated cells. Binding of IFN to the receptor complex will result in transcriptional activation of a large number of IFN-stimulated genes, which eventually confer antiviral activity by several different mechanisms (31) .
Viral pathogens induce the synthesis of type I IFN and other cytokines by triggering pathogen recognition receptors (PRR) such as Toll-like receptors (TLR) and retinoic acid-inducible gene I (RIG-I)-like helicases. Interestingly, most viruses trigger type I IFN responses both in
productively infected host cells and in immune cells which patrol infected organs. Early IFN synthesis is responsible for efficient host protection. However, successful viruses frequently encode factors that suppress production of IFN (8, 36) . At the moment, our knowledge on the contribution of various cell types to the production of IFN during infection is incomplete.
Detection of IFN-producing cells by standard immunological methods is complicated by the fact that type I IFN is rapidly secreted from virus-triggered cells and, thus, does usually not accumulate to high intracellular levels. Transgenic mice in which reporter genes are inserted into the coding regions of the IFN-α or -β genes are powerful tools to study virus-induced expression of IFN in vivo. Recently, a reporter mouse which expresses green-fluorescent protein in place of IFN-α6 was used to demonstrate that alveolar macrophages contribute to IFN synthesis in the lung of Newcastle disease virus-infected animals . To visualize IFN synthesis in various cell types of the brain during infection with La Crosse bunyavirus (16), we had employed a different reporter mouse in which the IFN-β coding region was replaced by firefly luciferase . These studies clearly showed that virus-encoded IFN-antagonistic factors may display their activities in particular cell types of infected organs but, at the same time, may fail to inhibit IFN synthesis by immune cells (16, 23) .
Influenza virus defense heavily relies on the innate immune system and uses virus-triggered IFN as effector. Accordingly, recombinant mice unable to respond to type I IFN are highly susceptible to influenza A viruses (20) . Resistance of mice against influenza virus further strongly depends on IFN-regulated genes which encode antiviral factors such as Mx and IFITM3 . This is in line with the view that IFN plays a decisive role in influenza virus defense. In spite of intensive investigations, surprisingly little is known about the cellular origin of type I IFN in influenza virus-infected lungs. Previous studies demonstrated that various cell types including macrophages, pneumocytes and dendritic cells are able to produce IFN after influenza virus infection (4, 12, 15, 17, 29) . However, the relative contribution of these cells to IFN production remained unclear.
In this report we used our IFN-β reporter mice to analyze the composition of the IFN-β source in lungs of animals infected with either wild-type influenza A virus or a virus mutant that cannot produce the IFN-antagonistic factor NS1. We show that virus-infected epithelial cells and macrophages produced the bulk of IFN-β after infection with the highly attenuated NS1-deficient mutant virus, whereas IFN-β synthesized in response to infection with wild-type influenza A virus mostly originated from CD11c + cells expressing or lacking macrophage markers. Viruses and infection of mice: Wild-type SC35M and mutant SC35M-ΔNS1 that cannot express the IFN-antagonistic factor NS1 were previously described (20) . Virus stocks were generated in Vero cells, MDCK cells or in MDCK cells expressing NS1 (21) . Age-matched animals (6-11 weeks old) were infected intranasally with 5x10 
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Mice
RESULTS
Epithelial cells and macrophages are the main producers of IFN-β in lungs of mice infected with influenza A virus mutant SC35M-ΔNS1
We previously reported that a highly attenuated variant of the influenza A virus strain SC35M To identify the cells producing IFN-β, we stained lung sections simultaneously for luciferase and cell type-specific markers. The most prominent IFN-β producers under these conditions were epithelial cells which line the airways and express the epithelial cell adhesion molecule (EpCAM) (Fig. 1B, left panel) (18) . In addition, lung macrophages which could be stained by the lectin BS-1 expressed IFN-β (Fig. 1B, right panel) (27, 32) .
To quantify IFN-β production by epithelial cells and macrophages, we used the Cre-LoxP system to establish reporter mice which express the transgene only in defined cell populations and measured luciferase activity in lung lysates (34) . For the current study, we used Nkx-Cre mice to generate animals in which IFN-β promoter-controlled luciferase expression is restricted to lung epithelial cells (35) . Further, we used LysM-Cre mice to generate reporter mice which express the luciferase gene in macrophages, granulocytes and at a low frequency in monocytes . In addition, we used CD11c-Cre mice which can express the luciferase gene in dendritic cells and certain macrophages (34) , as well as double-transgenic LysM/CD11c-Cre mice in which both LysM "Global" reporter mice, which are able to express the luciferase gene in all cell types , were included as reference. Age-matched groups of the different reporter mice were infected with SC35M-ΔNS1, lungs were extracted at various time points and luciferase activity in lung lysates was measured ( Fig. 2A) . In line with our findings from the histological analysis discussed above, we detected a strong IFN-β response in Nkx-Cre and LysM-Cre reporter mice, whereas luciferase activity measured in CD11c-Cre reporter mice was comparably low (Fig. 2A) . In accordance, luciferase activity in lungs of infected LysM/CD11c-Cre reporter mice was not significantly higher than in LysM-Cre reporter mice ( Fig. 2A) . The LysM gene in mice is highly active in alveolar macrophages but shows only low activity in dendritic cells (33) . On the other hand, macrophages and dendritic cells both express high levels of CD11c (33) . Our data thus suggest that alveolar as well as CD11c + macrophages contribute to the IFN-β response under these conditions. To confirm this interpretation of the data, we performed additional staining experiments in which the lectin BS-1 was used in combination with antibodies for CD11c. We observed that most luciferase-positive cells which expressed CD11c could also be stained with BS-1 (Fig. 1C) , indicating that they indeed represent lung macrophages.
Careful quantitative analysis of the data revealed that the combined luciferase signals of NkxCre, LysM-Cre and CD11c-Cre reporter mice at any given time post infection with SC35M-ΔNS1 reached about 55%-70% of the values measured in lungs of infected "global" reporter mice in which all cell types can produce luciferase (Fig. 2B) . The difference (white areas in (Fig. 3A) . In lungs analyzed at 48 h post infection, single scattered luciferase-expressing cells were present in heavily infected (Fig.   3B ) but not in uninfected lung areas (Fig. 3C) . The luciferase-positive cells appeared to contain either no or only low amounts of viral antigen. It should be noted that our staining approach can not distinguish between actively infected cells and cells that had simply engulfed viral antigen. Nevertheless, overall, these results are in good agreement with earlier findings which showed that during lethal SC35M infection, IFN-β production is low during the early stages of infection but reaches high levels at later stages of infection . It also nicely agrees with findings by others (26) that wild-type influenza viruses remain undetected by the immune system during the first two days post infection of the lung.
When lung sections of SC35M-infected reporter mice were stained with antibodies for luciferase and different cell markers, we observed that the majority of luciferase-positive cells in infected lungs at 48 h post infection expressed CD11c (Fig. 4) . Interestingly, a fraction of the CD11c + cells was also positive for the lung macrophage marker BS-1 (Fig. 4A, B) .
To quantify IFN-β production by different cell types during lethal infection with SC35M, we determined luciferase activity in lungs by using the same set of conditional reporter mice as described above for the SC35M-ΔNS1 mutant virus. In agreement with the histological findings, we found that wild-type SC35M virus induced the IFN- promoter-driven luciferase gene in infected lungs with delayed kinetics. In contrast to the situation in mice infected with SC35M-ΔNS1, substantial reporter gene expression was not observed before 48 h post infection (Fig. 5) . At all time points analyzed, expression of the luciferase reporter gene was rather weak in epithelial cells (Nkx-Cre mice), although it increased continuously over time (Fig. 5A ). Cells expressing LysM produced similar amounts of luciferase at 48, 72 and 96 h post infection, whereas luciferase activity in CD11c-Cre reporter mice clearly peaked at 48 h post infection and returned to substantially reduced levels at 72 and 96 h post infection (Fig.   5A ). In contrast to the situation in lungs of mice infected with SC35M-ΔNS1, after infection with wild-type SC35M luciferase gene expression in double-transgenic LysM/CD11c-Cre mice was only slightly different from CD11c-Cre single-transgenic mice (Fig. 5A ). These observations suggest that transiently appearing CD11c others . These authors further demonstrated that the migratory dendritic cells were not productively infected with influenza virus, which explains why IFN production by these cells was not inhibited by virus-encoded NS1. Our study showed that IFN-producing CD11c + cells which express LysM and bind to BS-1 remained in the infected tissue, suggesting that these cells are bona fide lung macrophages. However, it should be noted that plasmacytoid dendritic cells (pDCs) are also addressed by both LysM-Cre and CD11c-Cre, although at lower frequency than lung macrophages (14) . A recent study suggested that pDCs which appeared to sense virus using TLR7 contribute to IFN production at late stages of infections with influenza virus (17) . Thus, it seems likely that at least a fraction of the luciferase activity observed in our LysM/CD11c-Cre reporter mice originated from pDCs.
Conditional reporter mice expressing Cre recombinase exclusively in specific cell populations such as lung epithelial cells, macrophages/monocytes or CD11c + cells were used here. We noted that the sum of the luciferase signals measured in infected Nkx-Cre, LysM-Cre and CD11c-Cre mice was lower than the values measured in global reporter mice in which the modified IFN-β locus was rearranged in all cell types. There are at least two different explanations for these findings. The first possibility is that Cre-mediated recombination in the conditional reporter mice was incomplete as previously suggested by others (14) . The second possibility is that additional cell types which are not addressed by LysM-, CD11c-or Nkx-Cre contributed to IFN synthesis in virus-infected lungs. We believe that the second possibility most likely accounts for at least a fraction of the unknown activity at very late times post infection with wild-type influenza virus. It is well known that lethal influenza infection induces massive recruitment of monocytes, natural killer cells, T cells and B cells to the lung (19, 22, 25) . It is conceivable that these cells contributed substantially to the production of IFN observed at late stages of lethal infection with wild-type influenza virus in our experimental setting.
Previously, other researchers used a reporter mouse that synthesizes green fluorescent protein under control of the IFN-α6 gene promoter to study the innate immune response in the virusinfected lung . These authors reported that alveolar macrophages and conventional dendritic cells were the main producers of type I IFN in the lung after intranasal infection of mice with Newcastle disease virus (NDV), whereas epithelial cells did apparently not synthesize substantial amounts of IFN. In the light of our current findings, this result is surprising as NDV is well-known for its ability to trigger robust synthesis of type I IFN in a wide range of cells from many species (13, 28) . Since no information was provided whether NDV, which is a pathogen of chickens, is able to infect lung epithelial cells in mice, it remains unclear why NDV and NS1-deficient influenza viruses appear to differ in this respect.
In summary our work demonstrates that wild-type influenza virus uses NS1 to selectively inhibit production of type I IFN in cells that trigger very early antiviral responses, namely epithelial cells and lung macrophages. Moreover, our work demonstrates that the high levels of IFN seen at late times post infection with wild-type influenza virus mainly originate from different cells which are less affected by the virus-encoded IFN-antagonistic factor NS1. 
